EPRX
Eupraxia Pharmaceuticals Inc. Common StockNASDAQ
Healthcare • Biotechnology
Updated 1 day ago
Coverage limited
Factor tilt: Anti-Quality Small Cap
$6.68-8.74%
Close Oct 13, 2026
- Market cap
- $442.36M
- 1 month
- -17.2%
- 3 months
- +2.5%
- 1 year
- +10.0%
- 52-week range
- $5.33$9.10
- Dividend
- No dividends on record
- Short interest
- 12.2% of float6.8M shares · settled Sep 30, 2026 · -10.3% since Sep 15, 2026 · FINRA
End-of-day close from stored market data, not a live quote.
Portfolio context
Sign in to see your position size
We’ll show you if EPRX is in your portfolio and how much it contributes.
Sign inMarket context
Loading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
Smart money context
Holder IQ: HIGH
32 top institutions tracked
as of 2026-Q2 (filed 2026-09-02)
Last 13F trend: unchanged (light)
Unlock crowding heatmapUnlock filer discoveryInsider context
Sentiment: unknown
No recent insider trades detected.
Red flags: 0
Largest 13-F holders · Q2 2026
68 filers reported a long position in EPRX for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| Beutel, Goodman & Co Ltd. | $23.8M | 3.6M | -1.1% |
| Affinity Asset Advisors, LLC | $10.9M | 1.7M | +3.8% |
| BALYASNY ASSET MANAGEMENT L.P. | $8.9M | 1.4M | 0% |
| Vivo Capital, LLC | $8.9M | 1.4M | Unchanged |
| SCOTIA CAPITAL INC. | $8.8M | 1.3M | +0.1% |
| PFM Health Sciences, LP | $8M | 1.2M | +123.8% |
| GREAT POINT PARTNERS LLC | $7.9M | 1.2M | Unchanged |
| Jupiter Topco LLC | $6.9M | 1M | — |
| Rubric Capital Management LP | $5.7M | 867.4K | +25.5% |
| Ikarian Capital, LLC | $5.4M | 809.7K | -33.3% |
Get the Full Analysis for EPRX
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.